The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 26, 2021

Filed:

Feb. 23, 2017
Applicant:

Indiana University Research & Technology Corporation, Indianapolis, IN (US);

Inventors:

Natalia Bogatcheva, Westfield, IN (US);

Matthias Alexander Clauss, Indianapolis, IN (US);

Keith L. March, Carmel, IN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/395 (2006.01); C07K 16/24 (2006.01); A61P 11/00 (2006.01); A61P 29/00 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07K 16/24 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61P 11/00 (2018.01); A61P 29/00 (2018.01); A61K 2039/505 (2013.01); C07K 2317/55 (2013.01); C07K 2317/76 (2013.01);
Abstract

EMAPII is a monocyte- and endothelial cell-activating protein with prominent pro-apoptotic activity on endothelial and epithelial cells. Provided herein are compositions and methods for treating or preventing endothelial and epithelial apoptosis induced by EMAPII. More particularly, provided herein are compositions and methods for treating or preventing Influenza A virus (IAV)-induced weight loss, impairment of blood oxygenation, lung edema, and endothelial/epithelial apoptosis associated with IAV infections. In addition, anti-EMAPII therapy provides a novel complementary treatment strategy to existing anti-viral and anti-inflammatory approaches.


Find Patent Forward Citations

Loading…